Long-awaited diabetes NSF launched
October 27, 2003The long awaited diabetes national service framework has been launched with demanding new targets for the improvement of NHS services.By …
Investment banker to be Elan chief executive
October 27, 2003Elan
Kelly Martin, a former senior executive at Merrill Lynch, has been named chief executive of troubled Irish pharmaceutical company Elan.The …
Industry’s legal challenge to ‘arbitrary’ pricing
October 27, 2003European industry body EFPIA is seeking legal action against the Italian Government new reimbursement and pricing policy, which it believes …
Deadlock over access to medicines
October 27, 2003A row over patents on diabetes and asthma drugs has produced a deadlock in talks to improve access to medicines …
Pharmacia chief tipped for Schering role
October 27, 2003Current Pharmacia Chief Executive Fred Hassan has been tipped to take over the top job at Schering-Plough once the Pfizer/Pharmacia …
NHS diabetes czar appointed
October 27, 2003Leading diabetes specialist Dr Sue Roberts has been appointed as the new National Clinical Director for Diabetes, and will oversee …
Roche records $2.8bn loss in 2002
October 27, 2003Roche has recorded a $2.8 billion net loss for 2002 after writing off CHF9 billion costs following its embarrassing exit …
EU regulator submits expansion plans
October 27, 2003Medicines regulator the EMEA has asked the European Union for a subsidy increase of nearly 13% to pay for its …
Bayer denies Lipobay cover-up
October 27, 2003Bayer has refuted allegations that it concealed serious side-effects of its statin Lipobay before it was withdrawn in July 2001.US …
Pfizer picks US research ‘hotspot’ for trials centre
October 27, 2003Pfizer is to build a new $35 million clinical research centre in an R&D 'hotspot' in New Haven, Connecticut.Due to …
Abbott surprised by early Humira approval
October 27, 2003Abbott Laboratories says US approval of its rheumatoid arthritis product Humira has come earlier than expected, and will now increase …
ClinPhone signals European expansion
October 27, 2003UK clinical trials technology company ClinPhone is to develop its European business to serve clusters of pharmaceutical and biotech companies …
GSK faces growing opposition to US parallel trade policy
October 27, 2003GlaxoSmithKline is facing growing opposition from US patient groups and politicians to its attempt to block cheap drug imports from …
Milburn shortlists 50 hospitals for foundation status
October 27, 2003Health Secretary Alan Milburn has shortlisted 50 hospitals he believes are ready to take on foundation status before the next …
